Neuracle Stock

Neuracle is a neural technology company that provides clinical solutions for neurology patient care, functional neurosurgery and neural

Sign up today and learn more about Neuracle Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Neuracle Stock

Neuracle is a well-known enterprise in the field of neuroscience in China. They rely on Tsinghua University's independent innovation and international leading "brain-machine interface" technology, and are committed to innovative research in the fields of neuroscience, psychology, neuroengineering, etc., providing professional and complete solutions for the diagnosis, treatment and rehabilitation of clinical neurological diseases. Program. Their products cover a wide range of fields including clinical medicine, neuroscience, psychology, management marketing, etc., and take the lead in undertaking the National Twelfth Five-Year Science and Technology Support Program. The research and development results and products have been experts in neuroscience and clinical medicine at home and abroad. widely accepted.

Funding History

August 2019$60.0M

Management

Co-founder

Honglai Xu

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo